{
    "organizations": [],
    "uuid": "d2bcebaeb51c7da5248d02b0461473ee4da85dde",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-clementia-initiates-phase-2-mo-ped/brief-clementia-initiates-phase-2-mo-ped-trial-for-palovarotene-in-patients-with-multiple-osteochondromas-idUSASC09WN3",
    "ord_in_thread": 0,
    "title": "BRIEF-Clementia Initiates Phase 2 Mo-Ped Trial For Palovarotene In Patients With Multiple Osteochondromas",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 20 (Reuters) - CLEMENTIA:\n* CLEMENTIA INITIATES PHASE 2 MO-PED TRIAL FOR PALOVAROTENE IN PATIENTS WITH MULTIPLE OSTEOCHONDROMAS Source text for Eikon: (Reuters.Briefs@thomsonreuters.com)\n ",
    "published": "2018-04-20T18:33:00.000+03:00",
    "crawled": "2018-04-21T18:06:42.079+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "clementia",
        "clementia",
        "initiate",
        "phase",
        "trial",
        "palovarotene",
        "patient",
        "multiple",
        "osteochondroma",
        "source",
        "text",
        "eikon"
    ]
}